IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation
IQVIA becomes first DCT program to demonstrate commitment to data protection in Europe RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc. This marks the first … [Read more…]
